Classification of natural products as sources of drugs according to the biopharmaceutics drug disposition classification system(BDDCS)

被引:0
|
作者
LI Ji [1 ]
Caroline A.Larregieu [2 ]
Leslie Z.Benet [2 ]
机构
[1] Department of Clinical Pharmacy, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University
[2] Department of Bioengineering & Therapeutic Science, University of California
关键词
Biopharmaceutics Drug Disposition Classification System(BDDCS); Natural products(NPs); Dose number; Solubility and extent of metabolism;
D O I
暂无
中图分类号
R915 [药物生物学];
学科分类号
1007 ;
摘要
Natural products(NPs) are compounds that are derived from natural sources such as plants, animals, and microisms. Therapeutics has benefited from numerous drug classes derived from natural product sources. The Biopharmaceutics Drug position Classification System(BDDCS) was proposed to serve as a basis for predicting the importance of transporters and enzymes in determining drug bioavailability and disposition. It categorizes drugs into one of four biopharmaceutical classes according to their water solubility and extent of metabolism. The present paper reviews 109 drugs from natural product sources: 29% belong to class 1(high solubility, extensive metabolism), 22% to class 2(low solubility, extensive metabolism), 40% to class 3(high solubility, poor metabolism), and 9% to class 4(low solubility, poor metabolism). Herein we evaluated the characteristics of NPs in terms of BDDCS class for all 109 drugs as wells as for subsets of NPs drugs derived from plant sources as antibiotics. In the 109 NPs drugs, we piled 32 drugs from plants, 50%(16) of total in class 1, 22%(7) in class 2 and 28%(9) in class 3, none found in class 4; Meantime, the antibiotics were found 5(16%) in class 2, 22(71%) in class 3, and 4(13%) in class 4; no drug was found in class 1. Based on this classification, we anticipate BDDCS to serve as a useful adjunct in evaluating the potential characteristics of new natural products.
引用
收藏
页码:888 / 897
页数:10
相关论文
共 50 条
  • [1] Classification of natural products as sources of drugs according to the biopharmaceutics drug disposition classification system (BDDCS)
    Li Ji
    Larregieu, Caroline A.
    Benet, Leslie Z.
    CHINESE JOURNAL OF NATURAL MEDICINES, 2016, 14 (12) : 888 - 897
  • [2] The role of BCS (biopharmaceutics classification system) and BDDCS (biopharmaceutics drug disposition classification system) in drug development
    Benet, Leslie Z.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 102 (01) : 34 - 42
  • [3] The Biopharmaceutics Classification System (BCS) and the Biopharmaceutics Drug Disposition Classification System (BDDCS): Beyond guidelines
    Charalabidis, Aggelos
    Sfouni, Maria
    Bergstrom, Christel
    Macheras, Panos
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, 566 : 264 - 281
  • [4] Neural Network Models for Predicting Solubility and Metabolism Class of Drugs in the Biopharmaceutics Drug Disposition Classification System (BDDCS)
    Ashrafi, Aryan
    Teimouri, Kiarash
    Aghazadeh, Farnaz
    Shayanfar, Ali
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2024, 49 (01) : 1 - 6
  • [5] Neural Network Models for Predicting Solubility and Metabolism Class of Drugs in the Biopharmaceutics Drug Disposition Classification System (BDDCS)
    Aryan Ashrafi
    Kiarash Teimouri
    Farnaz Aghazadeh
    Ali Shayanfar
    European Journal of Drug Metabolism and Pharmacokinetics, 2024, 49 : 1 - 6
  • [6] Generative Topographic Mapping-Based Classification Models and Their Applicability Domain: Application to the Biopharmaceutics Drug Disposition Classification System (BDDCS)
    Gaspar, Helena A.
    Marcou, Gilles
    Horvath, Dragos
    Arault, Alban
    Lozano, Sylvain
    Vayer, Philippe
    Varnek, Alexandre
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2013, 53 (12) : 3318 - 3325
  • [7] State of the Art and Uses for the Biopharmaceutics Drug Disposition Classification System (BDDCS): New Additions, Revisions, and Citation References
    Bocci, Giovanni
    Oprea, Tudor I.
    Benet, Leslie Z.
    AAPS JOURNAL, 2022, 24 (02):
  • [8] State of the Art and Uses for the Biopharmaceutics Drug Disposition Classification System (BDDCS): New Additions, Revisions, and Citation References
    Giovanni Bocci
    Tudor I. Oprea
    Leslie Z. Benet
    The AAPS Journal, 24
  • [9] Using Biopharmaceutics Drug Disposition Classification System (BDDCS) Classification to Evaluate the DILI Causative Potential of Bile Salt Export Pump (BSEP) Inhibition
    Chan, R.
    Benet, L.
    INTERNATIONAL JOURNAL OF TOXICOLOGY, 2017, 36 (01) : 92 - 92
  • [10] Predicting Drug Disposition via Application of a Biopharmaceutics Drug Disposition Classification System
    Benet, Leslie Z.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2010, 106 (03) : 162 - 167